ERAS | ErascaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$14.64
+$0.59 (+4.20%)

Erasca (ERAS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2025, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily, above both on the weekly and between the two on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $14.64 vs 50 $15.35 / 200 $15.05
Projection
Death cross projected in 4 bars
Test
No active test
Last cross
Golden cross 30 Sep 2025 ยท projected 28 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $14.35 vs 50 $13.10 / 200 $5.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 2 Mar 2026 ยท projected 20 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $14.64 vs 50 $14.63 / 200 $16.54
Projection
No cross projected
Test
No active test
Last cross
Death cross 1 Oct 2026 ยท projected 30 bars out

Cross history

16
crosses on record since 2024
9 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Oct 2026Death4-hour30 bars outNot tested
1 Jul 2026Golden4-hour20 bars outNot tested
26 May 2026Death4-hour30 bars out5 bar cross test
week of 2 Mar 2026Golden steepweekly20 bars outNot tested
30 Sep 2025Golden moderatedaily28 bars outNot tested

About ERAS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$62.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.